Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05701215
Title Venetoclax After TKI to Target Persisting Stem Cells in CML (VARIANT)
Acronym VARIANT
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Thomas Ernst, PD Dr. med.
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.